4//SEC Filing
Hagen Elisabeth 4
Accession 0001209191-17-059249
CIK 0001006028other
Filed
Nov 2, 8:00 PM ET
Accepted
Nov 3, 5:12 PM ET
Size
7.7 KB
Accession
0001209191-17-059249
Insider Transaction Report
Form 4
Hagen Elisabeth
Director
Transactions
- Award
Stock Option (Right to Buy)
2017-11-02+200,000→ 200,000 totalExercise: $1.10Exp: 2027-11-02→ Common Stock (200,000 underlying) - Award
Common Stock
2017-11-02+150,000→ 150,000 total
Footnotes (2)
- [F1]Represents the issuance of restricted stock units (the "RSUs"). The RSUs vest and become exercisable as follows: (i) 50% of the RSUs will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2018 or January 15, 2018 and (ii) 50% of the RSUs will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2019 or January 15, 2019.
- [F2]The option shares shall vest and become exercisable as follows: (i) 50% of the option will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2018 or January 15, 2018 and (ii) 50% of the options will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2019 or January 15, 2019.
Documents
Issuer
PURE BIOSCIENCE, INC.
CIK 0001006028
Entity typeother
Related Parties
1- filerCIK 0001721211
Filing Metadata
- Form type
- 4
- Filed
- Nov 2, 8:00 PM ET
- Accepted
- Nov 3, 5:12 PM ET
- Size
- 7.7 KB